Qiancheng Shen
沈倩诚
Qiancheng Shen is the co-founder and CEO of Nutshell Therapeutics (宇道生物), a biotech company focused on allosteric drug discovery powered by AI and physics-based computation . In a 2025 speech at WAIC, Shen described the company's platform as making "undruggable" targets druggable by combining AI with physical computing to develop allosteric mechanism drugs . He has held the CEO role since at least 2022, when he was already framing allosteric drug R&D as a major future direction for China's biotech industry .
AI-generated — may contain errors, please verify.
Coverage
MaHui Spotlight | Over a Dozen MaHui Members Showcase AI Hardware Strength at WAIC
Unitree, Li Auto, Moonshot AI, Galaxy Universal, Mech-Mind, Keenon Robotics, Lynksoul, Biren Technology, and more than ten other MaHui member companies appeared at WAIC
MaHui Entrepreneurs | When Startup Life Becomes Their Way of Living
A Special, Ordinary Day
